[MALAKOF] YoY TTM Result on 30-Sep-2019 [#3]

Stock
[MALAKOF] MALAKOFF CORPORATION BERHAD
Announcement Date
20-Nov-2019
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2019
Quarter
30-Sep-2019 [#3]
Profit Trend
QoQ- 3.81%
YoY- 28.61%
Quarter Report
Latest QR
Upcoming QR
MALAKOF's Result
MALAKOF's Financial Summary
View:
Show?
TTM Result
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
Revenue 9,326,145 6,033,093 6,504,138 7,568,439 7,254,336 7,050,615 5,760,868 8.35%
PBT 640,046 479,247 507,983 549,686 450,620 736,365 610,914 0.77%
Tax -290,489 -151,529 -110,292 -199,746 -163,184 -312,067 -202,967 6.15%
NP 349,557 327,718 397,691 349,940 287,436 424,298 407,947 -2.54%
-
NP to SH 245,776 286,980 351,344 299,231 232,674 356,459 371,403 -6.64%
-
Tax Rate 45.39% 31.62% 21.71% 36.34% 36.21% 42.38% 33.22% -
Total Cost 8,976,588 5,705,375 6,106,447 7,218,499 6,966,900 6,626,317 5,352,921 8.99%
-
Net Worth 5,668,919 5,473,440 5,375,700 5,522,309 5,751,134 6,000,000 5,699,999 -0.09%
Dividend
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
Div 136,835 151,496 337,691 291,430 288,626 300,000 275,000 -10.97%
Div Payout % 55.68% 52.79% 96.11% 97.39% 124.05% 84.16% 74.04% -
Equity
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
Net Worth 5,668,919 5,473,440 5,375,700 5,522,309 5,751,134 6,000,000 5,699,999 -0.09%
NOSH 5,000,000 5,000,000 5,000,000 5,000,000 5,000,000 5,000,000 5,000,000 0.00%
Ratio Analysis
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
NP Margin 3.75% 5.43% 6.11% 4.62% 3.96% 6.02% 7.08% -
ROE 4.34% 5.24% 6.54% 5.42% 4.05% 5.94% 6.52% -
Per Share
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
RPS 190.84 123.45 133.09 154.87 147.58 141.01 115.22 8.76%
EPS 5.03 5.87 7.19 6.12 4.73 7.13 7.43 -6.29%
DPS 2.80 3.10 6.91 5.94 5.80 6.00 5.50 -10.63%
NAPS 1.16 1.12 1.10 1.13 1.17 1.20 1.14 0.29%
Adjusted Per Share Value based on latest NOSH - 5,000,000
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
RPS 186.52 120.66 130.08 151.37 145.09 141.01 115.22 8.35%
EPS 4.92 5.74 7.03 5.98 4.65 7.13 7.43 -6.63%
DPS 2.74 3.03 6.75 5.83 5.77 6.00 5.50 -10.95%
NAPS 1.1338 1.0947 1.0751 1.1045 1.1502 1.20 1.14 -0.09%
Price Multiplier on Financial Quarter End Date
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
Date 30/09/22 30/09/21 30/09/20 30/09/19 28/09/18 29/09/17 30/09/16 -
Price 0.615 0.815 0.945 0.86 0.875 1.07 1.65 -
P/RPS 0.32 0.66 0.71 0.56 0.59 0.76 1.43 -22.07%
P/EPS 12.23 13.88 13.14 14.05 18.49 15.01 22.21 -9.46%
EY 8.18 7.21 7.61 7.12 5.41 6.66 4.50 10.46%
DY 4.55 3.80 7.31 6.91 6.63 5.61 3.33 5.33%
P/NAPS 0.53 0.73 0.86 0.76 0.75 0.89 1.45 -15.43%
Price Multiplier on Announcement Date
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
Date 29/11/22 26/11/21 24/11/20 20/11/19 23/11/18 21/11/17 21/11/16 -
Price 0.645 0.755 0.91 0.885 0.865 0.995 1.40 -
P/RPS 0.34 0.61 0.68 0.57 0.59 0.71 1.22 -19.17%
P/EPS 12.83 12.86 12.66 14.45 18.27 13.96 18.85 -6.20%
EY 7.80 7.78 7.90 6.92 5.47 7.17 5.31 6.61%
DY 4.34 4.11 7.59 6.71 6.71 6.03 3.93 1.66%
P/NAPS 0.56 0.67 0.83 0.78 0.74 0.83 1.23 -12.28%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment